vaccines

FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)

3rd major COVID-19 vaccine shown to be effective and cheaper

All three vaccines must be approved by regulators before they can be widely distributed

 

Dr. Moncef Slaoui, chief adviser to Operation Warp Speed, speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. (AP Photo/Evan Vucci)

First COVID vaccines could arrive in U.S. on Dec. 12

FDA committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for emergency use authorization

 

A man wears a face mask as he walks along a street in Montreal, Sunday, November 15, 2020.THE CANADIAN PRESS/Graham Hughes

Potential vaccine news brightens dark day marked by rising COVID-19 cases, deaths in Canada

Canada is on track to receive six million doses of vaccine between January and March

 

FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)

Pfizer: COVID-19 shot 95% effective, seeking clearance soon

The study has enrolled nearly 44,000 people in the U.S. and five other countries.

FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)
Blood samples from volunteers participating in the National Institutes of Health-funded Moderna COVID-19 vaccine third phase clinical trail wait to be processed in a lab? at the University of Miami Miller School of Medicine in Miami, Fla., Wednesday, Sept. 2, 2020 in Miami. (AP Photo/Taimy Alvarez)

VIDEO: Growing number of Canadians plan to get vaccinated for COVID-19

The number is a jump from the 63 per cent who said they would take up such an offer one month ago

Blood samples from volunteers participating in the National Institutes of Health-funded Moderna COVID-19 vaccine third phase clinical trail wait to be processed in a lab? at the University of Miami Miller School of Medicine in Miami, Fla., Wednesday, Sept. 2, 2020 in Miami. (AP Photo/Taimy Alvarez)
FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that’s surging in the U.S. and around the world. (AP Photo/Hans Pennink, File)

VIDEO: 2nd coronavirus vaccine shows early success in U.S. tests

Moderna said its vaccine appears to be 94.5% effective, according to preliminary data

FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that’s surging in the U.S. and around the world. (AP Photo/Hans Pennink, File)
A vial of a plant-derived COVID-19 vaccine candidate, developed by Medicago, is shown in Quebec City on Monday, July 13, 2020 as part of the company’s Phase 1 clinical trials in this handout photo. Medicago says it has received promising early test results for its plant-derived vaccine for COVID-19. THE CANADIAN PRESS/HO, Medicago

Canadian company reports promising early Phase 1 test results of possible COVID-19 vaccine

Quebec City-based company says the side-effects were generally mild to moderate and short in duration

A vial of a plant-derived COVID-19 vaccine candidate, developed by Medicago, is shown in Quebec City on Monday, July 13, 2020 as part of the company’s Phase 1 clinical trials in this handout photo. Medicago says it has received promising early test results for its plant-derived vaccine for COVID-19. THE CANADIAN PRESS/HO, Medicago
FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. On Monday, Nov. 9, 2020, Pfizer said an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. (Courtesy of University of Maryland School of Medicine via AP, File)

Pfizer says COVID-19 vaccine is looking 90% effective

Pharmaceutical companies and various countries are in a global race to develop a vaccine against the virus

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. On Monday, Nov. 9, 2020, Pfizer said an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. (Courtesy of University of Maryland School of Medicine via AP, File)
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. THE CANADIAN PRESS/AP-Ted S. Warren

Canadians divided over mandatory COVID-19 vaccines, priority inoculations

Only 39 per cent of respondents said getting a vaccine should be mandatory

A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. THE CANADIAN PRESS/AP-Ted S. Warren
FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)

COVID-19 vaccine still months away but review team working to speed approvals

AstraZeneca has been the only vaccine maker to submit a COVID-19 vaccine for Canadian approval

FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)
Pharmacist Sean Simpson poses outside of his pharmacy in Virgil, Ont., Monday, October 5, 2020. Simpson’s pharmacy will be offering a drive through flu clinic this year. THE CANADIAN PRESS/Tara Walton

Doctors, pharmacies explore drive-thrus, outdoor clinics to meet flu shot demand

Many start their flu shot programs in October or early November

Pharmacist Sean Simpson poses outside of his pharmacy in Virgil, Ont., Monday, October 5, 2020. Simpson’s pharmacy will be offering a drive through flu clinic this year. THE CANADIAN PRESS/Tara Walton
Study participant Sean O’Connell is given a shot in this undated handout photo. Canadian researchers have launched a study to determine if a century-old vaccine against tuberculosis can offer some protection against COVID-19. Investigators at the University Health Network in Toronto say they hope to test a theory that Bacille Calmette Guerin, or BCG, can reduce the incidence and severity of COVID-19 infection. THE CANADIAN PRESS/HO - University Health Network

Canadian researchers explore whether TB vaccine offers COVID-19 protection

The trial is open to police, fire and health-care workers who are at greater risk of COVID-19 exposure

Study participant Sean O’Connell is given a shot in this undated handout photo. Canadian researchers have launched a study to determine if a century-old vaccine against tuberculosis can offer some protection against COVID-19. Investigators at the University Health Network in Toronto say they hope to test a theory that Bacille Calmette Guerin, or BCG, can reduce the incidence and severity of COVID-19 infection. THE CANADIAN PRESS/HO - University Health Network
A man wears a face mask as he waits outside a COVID-19 testing clinic in Montreal, Sunday, September 27, 2020, as the COVID-19 pandemic continues in Canada and around the world. A new survey finds many doctors fear they won’t have enough of the flu vaccine to meet demand.The Canadian Medical Association says more than 86 per cent of 1,459 respondents say they worry influenza season will put additional strain on the health-care system. Of those who offer the flu vaccine, half say they won’t have enough doses to meet demand and 85 per cent said the system needs more capacity. THE CANADIAN PRESS/Graham Hughes

Survey finds doctors worry supplies of flu vaccine, PPE will lag demand

Canadian health officials have said additional flu vaccines have been ordered to meet expected demand

A man wears a face mask as he waits outside a COVID-19 testing clinic in Montreal, Sunday, September 27, 2020, as the COVID-19 pandemic continues in Canada and around the world. A new survey finds many doctors fear they won’t have enough of the flu vaccine to meet demand.The Canadian Medical Association says more than 86 per cent of 1,459 respondents say they worry influenza season will put additional strain on the health-care system. Of those who offer the flu vaccine, half say they won’t have enough doses to meet demand and 85 per cent said the system needs more capacity. THE CANADIAN PRESS/Graham Hughes
FILE - In this Aug. 14, 2020, file photo, laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. (AP Photo/Natacha Pisarenko, File)

AstraZeneca COVID-19 vaccine study paused after one illness

An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries

FILE - In this Aug. 14, 2020, file photo, laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. (AP Photo/Natacha Pisarenko, File)
In this May 25, 2020, file photo, a lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. THE CANADIAN PRESS/AP-Sakchai Lalit
In this May 25, 2020, file photo, a lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. THE CANADIAN PRESS/AP-Sakchai Lalit
Senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London, Wednesday, Aug. 5, 2020. Scientists at Imperial College London are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. (AP Photo/Kirsty Wigglesworth)

Canada signs deals with two suppliers for potential COVID-19 vaccines

This is the third such deal Canada has made with COVID-19 vaccine developers

Senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London, Wednesday, Aug. 5, 2020. Scientists at Imperial College London are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. (AP Photo/Kirsty Wigglesworth)
Chief Public Health Officer Theresa Tam responds to a question during a news conference Tuesday August 25, 2020 in Ottawa. THE CANADIAN PRESS/Adrian Wyld

Misinformation online plays role in COVID-19 vaccine hesitancy: Tam

Dr. Tam says she is concerned about misinformation spread online about vaccines

Chief Public Health Officer Theresa Tam responds to a question during a news conference Tuesday August 25, 2020 in Ottawa. THE CANADIAN PRESS/Adrian Wyld
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

Canadian company urges human trials after COVID-19 vaccine results in mice

Providence Therapeutics says it needs federal funding to move forward

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world’s biggest COVID-19 vaccine test got underway Monday, July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it’s one of several candidates in the final stretch of the global vaccine race. (AP Photo/Ted S. Warren, File)

Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines

Earlier in July both Pfizer and Moderna reported positive results from smaller trials

FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world’s biggest COVID-19 vaccine test got underway Monday, July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it’s one of several candidates in the final stretch of the global vaccine race. (AP Photo/Ted S. Warren, File)
Chief Public Health Officer Dr. Theresa arrives to hold a press conference in Ottawa on Tuesday, Aug. 4, 2020. THE CANADIAN PRESS/Sean Kilpatrick

COVID-19 vaccine efforts provide hope but no silver bullet to stop pandemic: Tam

There are more than two dozen vaccines for COVID-19 in clinical trials around the world

Chief Public Health Officer Dr. Theresa arrives to hold a press conference in Ottawa on Tuesday, Aug. 4, 2020. THE CANADIAN PRESS/Sean Kilpatrick